| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 30 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 30 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 30 |
| 3 | TACROLIMUS | 26 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 26 |
| 5 | TACROLIMUS OINTMENT 0.1% | 26 |
| 6 | LAMIVUDINE | 22 |
| 7 | ADEFOVIR DIPIVOXIL | 21 |
| 8 | LAMIVUDINE ORAL | 21 |
| 9 | METHOTREXATE SODIUM | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 21 | 0.0165 |
| 1 | CIDOFOVIR ANHYDROUS | 19 | 0.0131 |
| 2 | FOSCARNET SODIUM | 19 | 0.0047 |
| 3 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 4 | ETRAVIRINE | 5 | 0.0011 |
| 5 | SALSALATE | 1 | 0.0011 |
| 6 | BUSULFAN | 16 | 0.0010 |
| 7 | DEXCHLORPHENIRAMINE MALEATE | 1 | 0.0010 |
| 8 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 1 | 0.0010 |
| 9 | ENTECAVIR | 11 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 31 | 0.0006 |
| 2 | Vitamin D3 Analog [EPC] | 8 | 0.0004 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0003 |
| 4 | Iron Chelator [EPC] | 9 | 0.0003 |
| 5 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 30 | 0.0003 |
| 7 | Protease Inhibitor [EPC] | 12 | 0.0003 |
| 8 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |